Speedway, IN, United States of America

Alvydas A Jarmas

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alvydas A Jarmas. Retrieved from https://idiyas.com/inventor/alvydas-a-jarmas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alvydas A Jarmas: Innovator in Antibiotic Synthesis

Introduction

Alvydas A Jarmas is a notable inventor based in Speedway, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of antibiotics. His work has implications for the development of essential medications that combat bacterial infections.

Latest Patents

Jarmas holds a patent for the compound "Crystalline 7-(R)-amino-3-(1'-pyridiniummethyl)-ceph-3-em-4-carboxylate." This compound serves as an intermediate in the synthesis of the cephalosporin antibiotic ceftazidime. His innovative approach to antibiotic development is reflected in this patent, which is crucial for advancing medical treatments.

Career Highlights

Alvydas A Jarmas is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to research and development. His role at the company has allowed him to contribute to groundbreaking advancements in drug synthesis and formulation.

Collaborations

Jarmas has worked alongside his coworker, Preston Charles Conrad, to further enhance the research and development efforts at Eli Lilly and Company. Their collaboration exemplifies the importance of teamwork in the innovation process.

Conclusion

Alvydas A Jarmas is a distinguished inventor whose work in antibiotic synthesis has made a significant impact on the pharmaceutical industry. His contributions continue to play a vital role in the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…